BSE filing, NSE: MANBA. Summary written from the filing by ALFA Finder's alert engine.
Manba Finance Ltd: key numbers
- Share price
- ₹145.39
- Market cap
- ₹730.4 Cr
- Revenue (annual)
- ₹328.2 Cr
- Net profit (annual)
- ₹45.36 Cr
- P/E (TTM)
- 14.3×Sector 19.8×
- Promoter holding
- 74.98%+0.00% QoQ
- FII holding
- 1.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manba Finance Ltd
All →Manba Finance Earnings Call Transcript: Key Takeaways
Solid growth in AUM and profitability driven by two-wheeler demand and geographical expansion.
- Call
- Guides 35% growth
Manba Finance Investor Presentation: Key Takeaways
H1 FY27: AUM INR 18,108 Mn (+20.7% YoY), NII INR 938 Mn (+37.5%), PAT INR 270 Mn (+27.7%). Q2 PAT INR 137 Mn (+20.2% YoY). Credit rating upgraded to A-.
Manba Finance Management Change
Manba Finance appointed Mrs. Neelam Tater as Non-Executive Independent Director. Mr. Parameshwaran relinquished his Chairperson role while continuing as Independent Director.
Manba Finance Debt & Borrowing
Manba Finance filed a Reg 54 security cover certificate for listed NCDs as at Sept 30, 2026. It confirms asset and security cover above 110% on secured debentures.
Manba Finance Dividend
Manba Finance declared a second interim dividend of Rs. 0.25 per equity share, payable by November 20, 2026. The record date is November 6, 2026.
Manba Finance Q2 FY27 Results: Net Profit ₹13.7 Cr, Up 20.2% YoY
Manba Finance Ltd reported revenue from operations of ₹97.7 Cr (+25.6% YoY) and net profit of ₹13.7 Cr (+20.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹13.7 Cr · +20.2% YoY
Other results update announcements
All →Medi Assist Healthcare Services Results Update
Medi Assist reported H1 FY27 results with higher revenue, EBITDA and profit year-on-year. It also announced a board-approved share buyback.
Neogen Chemicals Results Update
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.
Surani Steel Tubes Results Update
Surani Steel Tubes issued an earnings press release for H1 FY27, reporting revenue of Rs.290.86 Crore and PAT of Rs.5.94 Crore. The release states that both figures exceed the company's previous full-year records.
Shree Ganesh Remedies Results Update
Shree Ganesh Remedies released a press release on Q2 and H1 FY27 unaudited results, with Q2 revenue of ₹23.29 Crore, down 23% year-on-year. PAT fell 67% to ₹1.63 Crore.
Zen Technologies Results Update
Zen Technologies released its Q2 and H1 FY27 unaudited results, reporting consolidated Q2 revenue of ₹345.13 Crore, up 98.8% year-on-year. Order book stands at ₹1,375.70 Crore.
- Order book
- ₹1,376 Cr
Sai Parenterals Results Update
Sai Parenterals reported Q2FY27 consolidated revenue of Rs. 196 crore and PAT of Rs. 11 crore. Gross margin improved to 47.5%.